explore
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: Biogen joins immunology wave with $1.15 billion acquisition of HI
Next article: Biogen joins immunology wave with $1.15 billion acquisition of HI
explore
focus
-
At flashy new research hub, AstraZeneca lays out ambitious growth goals
2025-09-30 00:41 -
First medicine developed to treat MASH expected to be approved soon
2025-09-29 23:20 -
Questions and answers about ramping up H5N1 bird flu vaccine
2025-09-29 22:41 -
Change Healthcare cyberattack prompts Medicare loan program
2025-09-29 22:17 -
In his State of the Union, Biden takes clear aim at 'Big Pharma'
2025-09-29 22:13 -
Fentanyl is making it harder to start addiction treatment
2025-09-29 22:09